NRx Pharmaceuticals stockholders approve increased evergreen share reserve cap at annual meeting

NRX Pharmaceuticals, Inc.

Stockholder approved Amendment No. 1 to 2021 Omnibus Incentive Plan, effective March 23, 2026.
New annual share increase is lesser of 3,187,234 shares, 5% of outstanding, or Board-determined amount.
Class I directors Chaim Hurvitz and Michael Taylor re-elected with 9.86M and 9.89M For votes.
Appointment of Weinberg & Company as auditor ratified with 17.35M For (98.5% of votes cast).
Non-binding advisory vote on named executive officer compensation passed with 9.97M For.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.